These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 10372447
1. Security and maximal tolerated doses of fluvastatin in pediatric cancer patients. López-Aguilar E, Sepúlveda-Vildósola AC, Rivera-Márquez H, Cerecedo-Diaz F, Valdez-Sánchez M, Villasis-Keever MA. Arch Med Res; 1999; 30(2):128-31. PubMed ID: 10372447 [Abstract] [Full Text] [Related]
2. Long-term efficacy with fluvastatin as monotherapy and combined with cholestyramine (a 156-week multicenter study). French-Dutch Fluvastatin Study Group. Jacotot B, Banga JD, Waite R, Peters TK. Am J Cardiol; 1995 Jul 13; 76(2):41A-46A. PubMed ID: 7604796 [Abstract] [Full Text] [Related]
3. A comparison of fluvastatin 40 mg every other day versus 20 mg every day in patients with hypercholesterolemia. Rindone JP, Hiller D, Arriola G. Pharmacotherapy; 1998 Jul 13; 18(4):836-9. PubMed ID: 9692657 [Abstract] [Full Text] [Related]
4. Safety, tolerability, and pharmacokinetics of an extended-release formulation of fluvastatin administered once daily to patients with primary hypercholesterolemia. Sabia H, Prasad P, Smith HT, Stoltz RR, Rothenberg P. J Cardiovasc Pharmacol; 2001 May 13; 37(5):502-11. PubMed ID: 11336101 [Abstract] [Full Text] [Related]
5. Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis. Ballantyne CM, Pazzucconi F, Pintó X, Reckless JP, Stein E, McKenney J, Bortolini M, Chiang YT. Clin Ther; 2001 Feb 13; 23(2):177-92. PubMed ID: 11293552 [Abstract] [Full Text] [Related]
6. High-dose fluvastatin and bezafibrate combination treatment for heterozygous familial hypercholesterolemia. Eliav O, Schurr D, Pfister P, Friedlander Y, Leitersdorf E. Am J Cardiol; 1995 Jul 13; 76(2):76A-79A. PubMed ID: 7604804 [Abstract] [Full Text] [Related]
9. Changes in serum lipids when fluvastatin is substituted for lovastatin in the same doses. Rindone JP, Arriola G, Hiller D, Achacoso R. Am J Cardiol; 1997 Aug 01; 80(3):348-9. PubMed ID: 9264434 [Abstract] [Full Text] [Related]
10. Efficacy and safety of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin in hyperlipidemic patients treated with probucol. Sasaki S, Nakagawa M, Nakata T, Endo N, Miyao K, Kitamura K, Fukuyama M, Kitani T, Yamada C. Cardiology; 1997 Aug 01; 88(2):160-5. PubMed ID: 9096917 [Abstract] [Full Text] [Related]
13. Efficacy and safety of an extended-release formulation of fluvastatin for once-daily treatment of primary hypercholesterolemia. Ballantyne CM, McKenney J, Trippe BS. Am J Cardiol; 2000 Oct 01; 86(7):759-63. PubMed ID: 11018196 [Abstract] [Full Text] [Related]
14. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits. Mendoza S, Gamez R, Mas R, Goicochea E. Int J Tissue React; 2003 Oct 01; 25(3):81-9. PubMed ID: 14756189 [Abstract] [Full Text] [Related]